Entity family

Browse institutions

Universities, hospitals, research centres, networks, and public bodies. Examples include universities, NHS trusts, research networks.

1articles mentioning institutions

1institution mentions

1distinct institutions extracted

0%of mentions human-reviewed

Active filtersEntity: IMspire150 ×

IMspire150

This institution is selected. Its supporting articles are shown below.

IMspire1501

Articles mentioning IMspire150

1 articles · page 1 of 1

Efficacy of nivolumab plus relatlimab versus BRAF/MEK inhibitors for first-line treatment of BRAF-mutant advanced melanoma: A matching-adjusted indirect comparison

bmjonc · abstract · 2025-12-14 · 1 matching annotations

76.3%

IMspire150 COLUMBUS dabrafenib BRAF-mutant advanced melanoma atezolizumab cobimetinib binimetinib trametinib nivolumab vemurafenib+5 more

…et) and aggregate data from the COMBI-d/v, COLUMBUS, coBRIM and IMspire150 trials were used. Adults with untreated BRAF-mutant advanced me…